Diabetes

Sanofi, Medtronic join on diabetes drugs, devices

French drugmaker Sanofi and U.S. medical device manufacturer Medtronic Inc. have joined in a project to develop new combinations of drugs and devices for diabetes care.

Diseases, Conditions, Syndromes

Suboptimal usage of proton pump inhibitors common

(HealthDay)—For patients with gastroesophageal reflux disease (GERD), those who receive a proton pump inhibitor (PPI) prescription from gastroenterologists are more likely to be optimal users and have better symptom control, ...

Diabetes

Model predicts blood glucose levels 30 minutes later

A mathematical model created by Penn State researchers can predict with more than 90 percent accuracy the blood glucose levels of individuals with type 1 diabetes up to 30 minutes in advance of imminent changes in their levels—plenty ...

page 27 from 39